Clinical Trials Browser

Completed × Cholangiocarcinoma × Immune Checkpoint Inhibitors × Clear all

NCT05489692 2022-08-10

HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma

Gastrointestinal

Cholangiocarcinoma